Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
| pharmaceutical_companies:zymeworks [2022/04/28 17:22] liam | pharmaceutical_companies:zymeworks [2024/11/20 18:35] (current) liam [Affiliations] | ||
|---|---|---|---|
| Line 7: | Line 7: | ||
| ===== Affiliations ===== | ===== Affiliations ===== | ||
| - | In 2011, [[Merck]] entered an agreement with Zymeworks to use their Azymetric™ platform for the development and commercialization of bispecific antibodies against targets in multiple therapeutic fields. | + | In 2011, [[Merck]] entered an agreement with Zymeworks to use their Azymetric™ platform for the development and commercialization of bispecific antibodies against targets in multiple therapeutic fields.((//Merck & Co. Seals Bispecific Antibody Collaboration with Zymeworks.// |
| + | |||
| + | ===== External links ===== | ||
| + | |||
| + | * [[https:// | ||